(Q42456936)

English

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

scientific article published on June 1984

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 October 2017

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis (English)

1 reference

Europe PubMed Central

31 October 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A Lemay

1

1 reference

Europe PubMed Central

31 October 2017

R Maheux

2

1 reference

Europe PubMed Central

31 October 2017

N Faure

3

1 reference

Europe PubMed Central

31 October 2017

C Jean

4

1 reference

Europe PubMed Central

31 October 2017

A T Fazekas

5

1 reference

Europe PubMed Central

31 October 2017

language of work or name

0 references

publication date

1 June 1984

1 reference

Europe PubMed Central

31 October 2017

Fertility and Sterility

1 reference

Europe PubMed Central

31 October 2017

41

1 reference

Europe PubMed Central

31 October 2017

6

1 reference

Europe PubMed Central

31 October 2017

863-871

1 reference

Europe PubMed Central

31 October 2017

Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term intranasal luteinizing hormone-releasing hormone agonist treatment for contraception in women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Gonadotroph and corpus luteum responses to two successive intranasal doses of a luteinizing hormone-releasing hormone agonist at different days after the midcycle luteinizing hormone surge

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men**Supported in part by the National Cancer Institute of Canada; Hoechst AG, Frankf

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (D-ser[TBU]6-des-gly-NH2(10)) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary results on the clinical efficacy and safety of androgen inhibition by an LHRH agonist alone or combined with an antiandrogen in the treatment of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic clearance rates of luteinizing hormone in women during different phases of the menstrual cycle and while taking an oral contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of gonadotropin-releasing hormone receptors in human gonadal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of human granulosa cell progesterone secretion by a gonadotropin-releasing hormone agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Endometriosis: role of ovarian steroids in initiation, maintenance, and suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Gonadotropin-releasing hormone agonist suppresses ovulation, menses, and endometriosis in monkeys: an individualized, intermittent regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Nuclear estrogen binding sites in human endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947899-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0015-0282(16)47899-4

0 references

1 reference

Europe PubMed Central

31 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42456936&oldid=1958115118"